Company / Current Liabilities per Share
Oric Pharmaceuticals, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.23
FY2025
5-year range
$0.23 / $0.40
FY2021-FY2025
Trend
-34.7%
vs FY2024
Sector context
#185 of 210
Health Care
What the data says
Oric Pharmaceuticals, Inc.'s current liabilities per share of $0.23 is lower than 88% of companies in the Health Care sector (FY2025). Improved from $0.40 to $0.23 over the past 2 years.
Based on SEC 10-K filings.
0.23 in FY2025 with a 5-year CAGR of -10.7%.
Improved from $0.40 to $0.23 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 210This company $0.23 Sector average $23.79
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 34.7% year-over-year.
- Ranks #185 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.23 | -34.7% |
| FY2024 | $0.36 | -10.4% |
| FY2023 | $0.40 | +2.5% |
| FY2022 | $0.39 | -2.8% |
| FY2021 | $0.40 | -2.7% |
| FY2020 | $0.41 | -85.4% |
| FY2019 | $2.82 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026